Drug General Information
Drug ID
D09TED
Former ID
DNC012620
Drug Name
L-162234
Drug Type
Small molecular drug
Indication Discovery agent Terminated [545499]
Structure
Download
2D MOL

3D MOL

Formula
C31H33F3N4O5S
Canonical SMILES
CCCCC1=NN(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3S(=O)(=O)NC(=<br />O)OC(C)(C)C)C4=CC=CC=C4C(F)(F)F
InChI
1S/C31H33F3N4O5S/c1-5-6-15-27-35-38(25-13-9-8-12-24(25)31(32,33)34)29(40)37(27)20-21-16-18-22(19-17-21)23-11-7-10-14-26(23)44(41,42)36-28(39)43-30(2,3)4/h7-14,16-19H,5-6,15,20H2,1-4H3,(H,36,39)
InChIKey
IVFMKMCSJZZCKV-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Type-2 angiotensin II receptor Target Info Inhibitor [525772]
KEGG Pathway Neuroactive ligand-receptor interaction
Adrenergic signaling in cardiomyocytes
Renin-angiotensin system
Reactome Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways ACE Inhibitor Pathway
GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 545499Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003503)
Ref 525772J Med Chem. 2000 May 18;43(10):1993-2006.Quantized surface complementarity diversity (QSCD): a model based on small molecule-target complementarity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.